An artificial intelligence (AI)-based approach to clinical trial recruitment: The impact of Viz RECRUIT on enrollment in the EMBOLISE trial.
Ameer E HassanSaisree RaviSohum K DesaiHamzah M SaeiErmias A MekonnenWondwossen G TeklePublished in: Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences (2023)
The implementation of an AI-based software for the automatic screening of SDH patients increased the enrollment rate in the EMBOLISE trial, and the software performed well in a real-world, clinical trial setting.
Keyphrases
- artificial intelligence
- clinical trial
- phase ii
- machine learning
- deep learning
- phase iii
- study protocol
- big data
- end stage renal disease
- open label
- chronic kidney disease
- newly diagnosed
- ejection fraction
- healthcare
- prognostic factors
- primary care
- double blind
- health insurance
- patient reported outcomes
- data analysis
- peritoneal dialysis